Losartan Potassium Tablet
Product Images NDC 50090-5626

8 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-5626). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (102f37d5 4ea7 430a A75f Dbb6533301d8 01)

Image (102f37d5 4ea7 430a A75f Dbb6533301d8 01)
Chemical structure of losartan potassium, showing its molecular composition including the potassium ion.*
FDA Label Image

Image (102f37d5 4ea7 430a A75f Dbb6533301d8 02)

Image (102f37d5 4ea7 430a A75f Dbb6533301d8 02)
A line graph comparing the percentage of patients with a primary endpoint over 66 months for Atenolol and Losartan. The x-axis represents study months from 0 to 66, and the y-axis shows the percentage of patients from 0 to 16%. Atenolol is depicted with a dotted line and Losartan with a solid line. The chart includes a note on adjusted risk reduction of 13% with a p-value of 0.021.*
FDA Label Image

Image (102f37d5 4ea7 430a A75f Dbb6533301d8 03)

Image (102f37d5 4ea7 430a A75f Dbb6533301d8 03)
A line graph showing the percentage of patients with fatal and non-fatal stroke over study months for Atenolol and Losartan. The x-axis represents study months from 0 to 66, and the y-axis represents the percentage of patients from 0 to 8%. Atenolol is indicated by a dotted line, while Losartan is shown with a solid line. Text within the graph notes an adjusted risk reduction of 25% with a p-value of 0.001.*
FDA Label Image

Primary Endpoint Events Within Demographic Subgroups (102f37d5 4ea7 430a A75f Dbb6533301d8 04)

Primary Endpoint Events Within Demographic Subgroups (102f37d5 4ea7 430a A75f Dbb6533301d8 04)
Forest plot chart showing comparative hazard ratios and event rates for Losartan versus Atenolol across various patient subgroups (Overall, Age, Gender, Race, ISH, Diabetes, History of CVD) for Primary Composite and Stroke (Fatal/Non-fatal) outcomes. The chart displays numerical event rates, hazard ratio points, and confidence intervals, indicating the relative effect of Losartan compared to Atenolol.*
FDA Label Image

Image (102f37d5 4ea7 430a A75f Dbb6533301d8 05)

Image (102f37d5 4ea7 430a A75f Dbb6533301d8 05)
A line graph showing the percentage of patients with an event over time in months, comparing Losartan and placebo groups. The graph indicates a risk reduction of 16.1% with Losartan, with a p-value of 0.022. The X-axis represents months (0 to 48), and the Y-axis represents the percentage of patients with the event (0 to 60%).*
FDA Label Image

Image (38431fb6 7157 4be5 929a 0c65b7a29c55 343 1)

Image (38431fb6 7157 4be5 929a 0c65b7a29c55 343 1)
Losartan Potassium 25 mg tablet blister pack showing seven tablets arranged in a pattern resembling a downward arrow with circular and oval shapes. The label or brander A-S Medication Solutions is not visible on the image, but the product form and strength are evident from the physical blister configuration.*
FDA Label Image

Image (38431fb6 7157 4be5 929a 0c65b7a29c55 366 1)

Image (38431fb6 7157 4be5 929a 0c65b7a29c55 366 1)
Losartan Potassium 25 mg oral tablets package label from A-S Medication Solutions. The image shows a white rectangular carton with repeated black and gray geometric patterns resembling flower or star shapes on the upper right corner and lower left corner. The product name and strength are visible along with the labeler information on the front panel.*
FDA Label Image

Label Image (Lbl500905626)

Label Image (Lbl500905626)
Losartan Potassium 25 mg oral tablets label from A-S Medication Solutions. The label states each film-coated tablet contains Losartan Potassium 25 mg and instructs storage at 77 degrees F with protection from light. It shows a package count of 30 tablets and includes dosage and lot information along with the product NDC 50090-5626-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.